Effective asset management is critical for operational excellence, regulatory compliance, and long-term business sustainability. The ISO 55000 series provide a globally recognized framework for organizations to establish, implement, and improve asset management programs. This session will explore the evolution of ISO 55000 from its original 2014 version to the updated 2024 standards and how these updates impact asset management strategies. Attendees will delve into how these standards serve as a foundation for building and refining asset management programs that drive efficiency, reliability, and compliance. In this session you will learn how to:

• Decode the 2024 ISO 55000 updates and understand their impact on existing asset management frameworks.
• Bridge the gap between theory and execution by leveraging these updates to refine asset management strategies.
• Enhance regulatory alignment by integrating new standard requirements into compliance-driven environments.
• Benchmark best practices to ensure continuous improvement and long-term asset sustainability.

• Which specific updates in ISO 55000 (2024) do you see as most relevant to pharmaceutical asset management, and why?
• How can these updates help bridge the gap between compliance-driven maintenance and proactive asset reliability strategies?
• What challenges do pharmaceutical sites face in implementing these updated standards, and how can they be overcome?
• How can digitalization and data-driven decision-making be leveraged in alignment with ISO 55000 (2024) to optimize asset performance?
• What key metrics or benchmarks should be used to measure the success of ISO 55000-driven asset management improvements in pharma?

In the Harvesting Session the World Café moderators will summarize the results of their discussions and highlight key findings.